Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2
Non-alcoholic Fatty Liver Disease

Interventions: Drug: Exenatide
Drug: insulin glargine

First Posted Date: 2014-12-01

Last Posted Date: 2019-08-28

Lead Sponsor: Fudan University

Target Recruit Count: 76

Registration Number: NCT02303730

Locations: 🇨🇳
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
🇨🇳
Department of Endocrinology and Metabolism, Shanghai Minhang Central Hospital, Shanghai, Shanghai, China
🇨🇳
Department of Endocrinology and Metabolism,Huadong Hospital, Shanghai, Shanghai, China

and more 2 locations

Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial

Phase 3

Completed

Conditions: Kawasaki Disease

Interventions: Drug: Infliximab
Drug: IVIG

First Posted Date: 2014-11-21

Last Posted Date: 2016-02-03

Lead Sponsor: Fudan University

Target Recruit Count: 40

Registration Number: NCT02298062

Locations: 🇨🇳
Children Hospital of Fudan University, Shanghai, Shanghai, China

A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients

Phase 2

Conditions: Metastatic Colon Cancer

Interventions: Procedure: resection of primary lesion
Drug: XELOX

First Posted Date: 2014-11-14

Last Posted Date: 2015-11-11

Lead Sponsor: Fudan University

Target Recruit Count: 130

Registration Number: NCT02291744

Locations: 🇨🇳
Fudan University Cancer Hospital, ShangHai, Shanghai, China

Intervention Study on the Health Impact of Air Filters in Chinese Adults

Not Applicable

Completed

Conditions: Pulmonary Function
Coagulation
Blood Pressure
Inflammation

Interventions: Behavioral: Air purifiers

First Posted Date: 2014-09-15

Last Posted Date: 2016-01-13

Lead Sponsor: Fudan University

Target Recruit Count: 35

Registration Number: NCT02239744

Locations: 🇨🇳
Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China

Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators

Not Applicable

Completed

Conditions: Inflammation
Blood Coagulation Disorders
Autonomic Nervous System Imbalance
Vasoconstriction
Blood Pressure

Interventions: Behavioral: Wear respirator

First Posted Date: 2014-09-12

Last Posted Date: 2016-05-06

Lead Sponsor: Fudan University

Target Recruit Count: 28

Registration Number: NCT02238028

Locations: 🇨🇳
Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China

National Study on Autism Spectrum Disorder in China

Completed

Conditions: Autism Spectrum Disorders

First Posted Date: 2014-07-25

Last Posted Date: 2017-05-16

Lead Sponsor: Fudan University

Target Recruit Count: 143755

Registration Number: NCT02200679

Locations: 🇨🇳
The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
🇨🇳
Capital Institute of Pediatrics, Beijing, Beijing, China
🇨🇳
Harbin Medical University, Harbin, Heilongjiang, China

and more 5 locations

Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis

Phase 4

Completed

Conditions: C.Delivery; Surgery (Previous), Gynecological

Interventions: Drug: rocuronium
Drug: cisatracurium

First Posted Date: 2014-07-18

Last Posted Date: 2020-08-12

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT02194855

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

Phase 2

Withdrawn

Conditions: Carcinoma Breast Stage IV

Interventions: Drug: Anastrozole
Drug: Fulvestrant

First Posted Date: 2014-05-16

Last Posted Date: 2015-12-29

Lead Sponsor: Fudan University

Registration Number: NCT02140437

A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

Phase 2

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Docetaxel
Drug: Fulvestrant

First Posted Date: 2014-05-13

Last Posted Date: 2018-01-23

Lead Sponsor: Fudan University

Target Recruit Count: 22

Registration Number: NCT02137083

Locations: 🇨🇳
Fudan University Cancer Hospital, Shanghai, China

Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Phase 4

Completed

Conditions: Myocardial Infarction
Percutaneous Coronary Intervention
Thrombolytic Therapy

Interventions: Drug: normal saline
Drug: Prourokinase
Drug: Tirofiban

First Posted Date: 2014-05-06

Last Posted Date: 2018-08-07

Lead Sponsor: Fudan University

Target Recruit Count: 362

Registration Number: NCT02131220

Locations: 🇨🇳
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy